Cann Group Limited (CNGGF)

Market Cap	5.98M +5.9%
Revenue (ttm)	6.68M -27.2%
Net Income	14.05M
EPS	0.01
Shares Out	n/a
PE Ratio	0.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Open	0.0034
Previous Close	0.0034
Day's Range	0.0034 - 0.0034
52-Week Range	0.0015 - 0.0278
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNGGF

Financial Performance

Financial numbers in AUD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 4, 2026

Data Sources Report a data error